Efficacy and safety of alemtuzumab in 113 patients with active relapsing-remitting MS: one-year follow-up in France

Affiliation auteurs!!!! Error affiliation !!!!
TitreEfficacy and safety of alemtuzumab in 113 patients with active relapsing-remitting MS: one-year follow-up in France
Type de publicationJournal Article
Year of Publication2017
AuteursAyrignac X, Collongues N, de Seze J, Vermersch P, Biotti D, Brassat D, Vukusic S, Durand-Dubief F, Edan G, LePage E, Deburghgraeve V, Maillart E, Papeix C, Alla P, Berger E, Bourre B, Casez O, Pittion S, Debouverie M, Theaudin M, Derache N, Defer G, Gout O, Deschamps R, Tourbah A, Zagnoli F, Ruet A, Ouallet J, Brochet B, Manchon E, Moreau T, Fromont A, Clavelou P, Guennoc AMarie, Camdessanche J-P, Carpentier A, Coman IAntoanela, Audoin B, Pelletier J, Magy L, Ciron J, Wiertlevski S, Laplaud D, De Broucker T, Frenay CLebrun, Cohen M, Labauge P
JournalNEUROLOGY
Volume88
Date PublishedAPR 18
Type of ArticleMeeting Abstract
ISSN0028-3878